Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Genomics Licensed to Offer Colorectal Cancer Test in Florida

This article has been updated to correct details regarding the Florida state license.

NEW YORK (GenomeWeb) – Colorectal cancer testing firm Clinical Genomics today said that it has received licensure from Florida authorities to offer its Colvera colorectal cancer test to residents of the state.

The license from the Florida Agency for Healthcare Administration allows the Bridgewater, New Jersey-based firm to offer the liquid biopsy test for identifying ctDNA for detecting residual disease and early detection of recurrence in post-treatment patients.

Florida is one of a handful of states that requires state licensures — in addition to CLIA certification of labs — for firms to provide certain tests to state residents. As a result of the licensure, Clinical Genomics will be able to make Colvera available to about 10,000 patients in Florida who are treated for colorectal cancer each year, Clinical Genomics Pathology Vice President of Operations and laboratory site director John Alsobrook said in a statement.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.